The Cigna Group (CI) Institutional Ownership & Insider Trading

1,686 institutions reported holding The Cigna Group shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 21 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CIThe Cigna GroupFollow CI — free

Healthcare Plans · Healthcare

—

Price chart with a free account

Market cap: 81.1B
P/E TTM: 12.7
Dividend yield: 2.0%
52-week: —
Next earnings: 5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

1,686 institutions held 90.0% of the shares. Across filers that reported both quarters, shares held changed -0.1%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	1,686	238	-0.1%	573	107	486	68
Mar 26	1,634	235	+1.4%	584	93	455	84
Dec 25	1,612	234	-3.8%	476	88	549	104
Sep 25	1,573	239	+3.2%	484	69	531	167
Jun 25	1,686	235	-2.2%	538	118	486	71
Mar 25	1,641	236	-1.2%	487	135	524	99
Dec 24	1,581	243	-1.3%	432	65	555	183
Sep 24	1,642	238	-3.8%	484	82	483	65

The Cigna Group — questions

Who owns The Cigna Group stock?: 1,686 institutions reported The Cigna Group shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.9%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%), STATE STREET CORP (4.8%).
Are The Cigna Group insiders buying or selling?: 21 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from The Cigna Group's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.